LB Pharmaceuticals Inc Common Stock LBRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$19.05M-259% | -$11.47M-126% | -$3.56M+74.9% | -$4.87M+82.4% | -$5.31M+67.3% | ||
| $82K+3.8% | $85K+6.3% | —— | —— | $79K— | ||
| $2.57M+305% | $2.34M+2.8% | —— | —— | $634K— | ||
| $0-100% | —— | —— | —— | $119K— | ||
| $3.46M+220% | —— | —— | —— | -$2.89M-331% | ||
| $10.22M+12,412% | $11.3M+2,472% | —— | —— | -$83K-119% | ||
| -$99K-5,050% | -$98K-553% | —— | —— | $2K+113% | ||
| -$23.29M-187% | -$18.1M-220% | —— | —— | -$8.13M— | ||
| $32K+52.4% | $40K-83.2% | —— | —— | $21K— | ||
| $0-100% | $1K-99.9% | —— | —— | $2.5M— | ||
| -$32K-101% | -$40K-100% | —— | —— | $4.98M— | ||
| —— | $0-100% | —— | —— | —— | ||
| —— | $0-100% | —— | —— | —— | ||
| $93.83M— | —— | —— | —— | $0-100% | ||
| $70.51M+2,340% | —— | —— | —— | -$3.15M— | ||
| —— | $2500.0% | $2500.0% | $2500.0% | $2500.0% | ||
| -$17K-242% | -$17K-128% | —— | —— | $12K— | ||
| $82K+3.8% | —— | —— | —— | $79K— | ||
| $0-100% | —— | —— | —— | $119K— | ||
| -$99K-5,050% | -$98K-553% | —— | —— | $2K+113% | ||
| $10.22M+12,412% | $11.3M+2,472% | —— | —— | -$83K-119% | ||
| —— | $0-100% | —— | —— | —— | ||
| $50K-62.4% | $47K-64.4% | —— | —— | $133K— | ||
| —— | $2K— | $2K— | $2K— | $2K— | ||
| —— | $625K-91.7% | $625K-91.7% | $625K-91.7% | $625K-91.7% | ||
| —— | $625.25K-89.4% | $625.25K-89.4% | $625.25K-89.4% | $625.25K-89.4% | ||
| $0-100% | —— | —— | —— | $2.5M— | ||
| $6.2M— | —— | —— | —— | $0— | ||
| —— | $1.17M— | —— | —— | —— | ||
| —— | $81.94M— | $81.94M— | $81.94M— | $81.94M— | ||
| $100M— | —— | —— | —— | $0— | ||
| $29K— | —— | —— | —— | $0-100% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $28.57M— | $28.57M— | $28.57M— | $28.57M— | ||
| $200K-74.0% | —— | —— | —— | $768K— | ||
| -$99K-5,050% | -$98K-553% | —— | —— | $2K+113% | ||
| —— | $0-100% | —— | —— | —— | ||
| —— | $0-100% | —— | —— | —— | ||
| -$23.32M-186% | -$18.14M-207% | —— | —— | -$8.15M— | ||
| -$23.32M-186% | -$18.14M-207% | —— | —— | -$8.15M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does LB Pharmaceuticals Inc Common Stock generate?
- LB Pharmaceuticals Inc Common Stock (LBRX) generated -$55.2M in operating cash flow over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's free cash flow?
- After $331.0K of capital expenditures, LB Pharmaceuticals Inc Common Stock's free cash flow was -$55.5M over the trailing twelve months.
- Where does LB Pharmaceuticals Inc Common Stock's cash flow data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.